
Marshall Wace’s Regenxbio RGNX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.83M | Sell |
222,342
-3,238
| -1% | -$26.6K | ﹤0.01% | 1490 |
|
2025
Q1 | $1.61M | Buy |
+225,580
| New | +$1.61M | ﹤0.01% | 1465 |
|
2024
Q3 | – | Sell |
-39,093
| Closed | -$457K | – | 2685 |
|
2024
Q2 | $457K | Buy |
+39,093
| New | +$457K | ﹤0.01% | 1813 |
|
2023
Q4 | – | Sell |
-33,249
| Closed | -$547K | – | 2218 |
|
2023
Q3 | $547K | Buy |
+33,249
| New | +$547K | ﹤0.01% | 1421 |
|
2021
Q1 | – | Sell |
-8,903
| Closed | -$404K | – | 2450 |
|
2020
Q4 | $404K | Buy |
+8,903
| New | +$404K | ﹤0.01% | 1431 |
|
2020
Q3 | – | Sell |
-58,445
| Closed | -$2.15M | – | 1835 |
|
2020
Q2 | $2.15M | Buy |
58,445
+55,514
| +1,894% | +$2.05M | 0.02% | 739 |
|
2020
Q1 | $95K | Buy |
+2,931
| New | +$95K | ﹤0.01% | 1317 |
|
2019
Q1 | – | Sell |
-38,821
| Closed | -$1.63M | – | 1997 |
|
2018
Q4 | $1.63M | Sell |
38,821
-317,965
| -89% | -$13.3M | 0.02% | 773 |
|
2018
Q3 | $26.9M | Buy |
356,786
+151,737
| +74% | +$11.5M | 0.23% | 118 |
|
2018
Q2 | $14.7M | Buy |
+205,049
| New | +$14.7M | 0.22% | 132 |
|